Totally agree Actionaire
currently chart set up looks as good as it gets
new highs, rising volumes, new institutional interest
upside looks exponentially open ended … if slides accurate and the human trials keep kicking goals
above slide indicates RP11 commercial drug launch would translate into $1 billion per annum in profitability … 10x multiple would presumably deliver ~$10 billion market capitalisation
don’t want to think about impact of the other drugs … especially the kidney cyst drug
Totally agree Actionairecurrently chart set up looks as good as...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.025(2.11%) |
Mkt cap ! $676.5M | |||
| Open | High | Low | Value | Volume |
| $1.19 | $1.20 | $1.16 | $45.30K | 38.23K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4346 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 563 | 1 |
View Market Depth
| Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |